The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, January 24, 2019
Inovio announced a second patient with HPV-related head and neck cancer treated with INO-3112 achieved full remission after subsequent treatment with ...
read more
Wednesday, January 16, 2019
AIVITA Biomedical announced the FDA has cleared its IND application for a Phase 1B clinical trial investigating the company's ROOT OF CANCER ...
read more
SIRION Biotech has signed a license and collaboration agreement with Denali Therapeutics, a biopharmaceutical company developing product candidates ...
read more
Friday, December 28, 2018
Perlara announced an APOL1 kidney disease PerlQuest co-development partnership with Rambam Medical Center and nephrologist and kidney disease ...
read more
Liveyon has voluntarily recalled all ReGen Series products due to reported possible adverse reactions.
read more
Tuesday, September 25, 2018
The FDA has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of ...
read more
Monday, September 17, 2018
Lin BioScience announced the FDA has granted Rare Pediatric Disease designation to LBS-008, a first-in-class oral therapy for the treatment of ...
read more
Bioasis and Bioagilytix announced a collaboration to partner on the development and validation of bioanalytical methods to support and advance the xB3...
read more
Recursion announced the FDA has cleared an IND application for a Phase 1 clinical trial of REC-994 in the treatment of cerebral cavernous malformation...
read more
NuMedii announced the formation of a strategic research collaboration with Yale School of Medicine and Brigham and Women's Hospital with the goal of ...
read more
On 21 June 2018, the FDA withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017.
read more
The FDA approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy in patients...
read more
Based on the FDA’s guidance, Kadmon plans to initiate an open-label, two-arm, pivotal Phase 2 clinical trial to support the potential registration of ...
read more
Mirata BioPharma announced it is now a Resident Company at Johnson & Johnson Innovation, JLABS at Texas Medical Center located in Houston, TX.
read more
Soligenix announced the European Commission has granted orphan drug designation to the company's recombinant modified ricin toxin A-chain subunit for ...
read more